The effects of intrapartum synthetic oxytocin on maternal postpartum mood: findings from a prospective observational study

. 2019 Aug ; 22 (4) : 485-491. [epub] 20181010

Jazyk angličtina Země Rakousko Médium print-electronic

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid30306269

Grantová podpora
17-10464S Czech Science Foundation - International

Odkazy

PubMed 30306269
PubMed Central PMC6647378
DOI 10.1007/s00737-018-0913-3
PII: 10.1007/s00737-018-0913-3
Knihovny.cz E-zdroje

Postpartum depression (PPD) affects up to 19% of all mothers, with detrimental effects on both mother and child. The antidepressant and anxiolytic effects of plasma oxytocin are well-documented, but it is still disputable whether synthetic oxytocin (synOT) may protect women against postpartum mood alterations. The current study examined the association between synOT intrapartum and maternal mood postpartum using a prospective design. Two hundred sixty women were screened for depressive symptoms in the last trimester of pregnancy and then again 6 weeks and 9 months postpartum using the Edinburgh Postnatal Depression Scale. They also completed Maternity Blues Questionnaire in the first postpartum week. The data concerning the intrapartum interventions and health status of the newborn were extracted from the medical records. Cox proportional hazards regression adjusted for a history of depression, mode of delivery, and childbirth experience showed that synOT predicted a significantly lower risk of PPD (HR = 0.65, 95% CI 0.45-0.95, p = 0.025). The risk factors for PPD included a history of depression (HR = 3.20, 95% CI 2.33-4.40, p < 0.001) and negative childbirth experience (HR = 1.39, 95% CI 1.01-1.90, p = 0.040). Logistic regression adjusted for the same covariates found no significant effect of synOT on maternity blues (OR = 0.64, 95% CI 0.31-1.32, p = 0.23). While synOT administered intrapartum does not affect maternal mood immediately, it may come to effect some weeks after childbirth to protect mothers from developing PPD symptoms.

Zobrazit více v PubMed

Boyd RC, Le H, Somberg R. Review of screening instruments for postpartum depression. Arch Women’s Ment Health. 2005;8:141–153. doi: 10.1007/s00737-005-0096-6. PubMed DOI

Breedlove G, Fryzelka D. Depression screening during pregnancy. J Midwifery Womens Health. 2011;56:18–25. doi: 10.1111/j.1542-2011.2010.00002.x. PubMed DOI

Cornish AM, McMahon CA, Ungerer JA, Barnett B, Kowalenko N, Tennant C. Postnatal depression and infant cognitive and motor development in the second postnatal year: the impact of depression chronicity and infant gender. Infant Behav Dev. 2005;28:407–417. doi: 10.1016/j.infbeh.2005.03.004. DOI

Cox J, Holden J (2003) Perinatal mental health: a guide to the Edinburgh Postnatal Depression Scale (EPDS). Royal College of Psychiatrists

Feldman R, Granat A, Pariente C, Kanety H, Kuint J, Gilboa-Schechtman E. Maternal depression and anxiety across the postpartum year and infant social engagement, fear regulation, and stress reactivity. J Am Acad Child Adolesc Psychiatry. 2009;48:919–927. doi: 10.1097/CHI.0b013e3181b21651. PubMed DOI

Forman DR, O'hara MW, Stuart S, Gorman LL, Larsen KE, Coy KC. Effective treatment for postpartum depression is not sufficient to improve the developing mother–child relationship. Dev Psychopathol. 2007;19:585–602. doi: 10.1017/S0954579407070289. PubMed DOI

Garfield L, et al. Depressive symptoms in the second trimester relate to low oxytocin levels in African-American women: a pilot study. Arch Womens Ment Health. 2015;18:123–129. doi: 10.1007/s00737-014-0437-4. PubMed DOI PMC

Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005;106:1071–1083. doi: 10.1097/01.AOG.0000183597.31630.db. PubMed DOI

Grace SL, Evindar A, Stewart DE. The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. Arch Womens Ment Health. 2003;6:263–274. doi: 10.1007/s00737-003-0024-6. PubMed DOI

Gu V, et al. Intrapartum synthetic oxytocin and its effects on maternal well-being at 2 months postpartum. Birth. 2016;43:28–35. doi: 10.1111/birt.12198. PubMed DOI

Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 2003;54:1389–1398. doi: 10.1016/S0006-3223(03)00465-7. PubMed DOI

Hinshaw K, Simpson S, Cummings S, Hildreth A, Thornton J. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women. BJOG. 2008;115:1289–1295. doi: 10.1111/j.1471-0528.2008.01819.x. PubMed DOI

Jobst A, et al. Oxytocin course over pregnancy and postpartum period and the association with postpartum depressive symptoms. Arch Womens Ment Health. 2016;19:571–579. doi: 10.1007/s00737-016-0644-2. PubMed DOI

Kennerley H, Gath D. Maternity blues: I. Detection and measurement by questionnaire. Br J Psychiatry. 1989;155:356–362. doi: 10.1192/bjp.155.3.356. PubMed DOI

Kirsch P, et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005;25:11489–11493. doi: 10.1523/JNEUROSCI.3984-05.2005. PubMed DOI PMC

Kroll-Desrosiers AR, Nephew BC, Babb JA, Guilarte-Walker Y, Moore Simas TA, Deligiannidis KM. Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year. Depress Anxiety. 2017;34:137–146. doi: 10.1002/da.22599. PubMed DOI PMC

Lemola S, Stadlmayr W, Grob A. Maternal adjustment five months after birth: the impact of the subjective experience of childbirth and emotional support from the partner. J Reprod Infant Psychol. 2007;25:190–202. doi: 10.1080/02646830701467231. DOI

Massey SH, Backes KA, Schuette SA. Plasma oxytocin concentration and depressive symptoms: a review of current evidence and directions for future research. Depress Anxiety. 2016;33:316–322. doi: 10.1002/da.22467. PubMed DOI PMC

Matthey S, Guedeney A, Starakis N, Barnett B. Assessing the social behavior of infants: use of the ADBB scale and relationship to mother’s mood. Infant Ment Health J. 2005;26:442–458. doi: 10.1002/imhj.20061. PubMed DOI

Murray L, Fiori-Cowley A, Hooper R, Cooper P. The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev. 1996;67:2512–2526. doi: 10.2307/1131637. PubMed DOI

Ohoka H, et al. Effects of maternal depressive symptomatology during pregnancy and the postpartum period on infant-mother attachment. Psychiatry Clin Neurosci. 2014;68:631–639. doi: 10.1111/pcn.12171. PubMed DOI

Skrundz M, Bolten M, Nast I, Hellhammer DH, Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology. 2011;36:1886–1893. doi: 10.1038/npp.2011.74. PubMed DOI PMC

Sutter-Dallay A-L, Murray L, Dequae-Merchadou L, Glatigny-Dallay E, Bourgeois M-L, Verdoux H. A prospective longitudinal study of the impact of early postnatal vs. chronic maternal depressive symptoms on child development. Eur Psychiatry. 2011;26:484–489. doi: 10.1016/j.eurpsy.2010.05.004. PubMed DOI

Takacs L, Smolik F, Mlikova Seidlerova J, Cepicky P, Hoskovcova S (2016) Postpartum blues - a Czech adaptation of the Maternity Blues Questionnaire. Ceska Gynekol 81:355–368 PubMed

Watanabe M, Wada K, Sakata Y, Aratake Y, Kato N, Ohta H, Tanaka K. Maternity blues as predictor of postpartum depression: a prospective cohort study among Japanese women. J Psychosom Obstet Gynecol. 2008;29:211–217. doi: 10.1080/01674820801990577. PubMed DOI

Werner E, Miller M, Osborne LM, Kuzava S, Monk C. Preventing postpartum depression: review and recommendations. Arch Womens Ment Health. 2015;18:41–60. doi: 10.1007/s00737-014-0475-y. PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...